P Boyle

Summary

Affiliation: European Institute of Oncology
Country: Italy

Publications

  1. ncbi Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Int Angiol 22:250-62. 2003
  2. ncbi The relationship between lower urinary tract symptoms and health status: the UREPIK study
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    BJU Int 92:575-80. 2003
  3. ncbi The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    BJU Int 92:719-25. 2003
  4. ncbi The prevalence of male urinary incontinence in four centres: the UREPIK study
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    BJU Int 92:943-7. 2003
  5. ncbi Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
    P Maisonneuve
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Lancet 354:93-9. 1999
  6. ncbi The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    BJU Int 92:409-14. 2003
  7. ncbi Larynx cancer in Slovakia and the role of anatomical subsites
    G Severi
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Oral Oncol 35:564-70. 1999
  8. ncbi Projections to the end of the century of mortality from major cancer sites in Italy
    E Negri
    Istituto di Ricerche Farmacologiche M. Negri, Milan, Italy
    Tumori 76:420-8. 1990
  9. ncbi Age at any birth and breast cancer risk
    C Robertson
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milano, Italy
    Stat Med 17:431-45. 1998
  10. pmc A case-control study of diabetes mellitus and cancer risk
    C La Vecchia
    Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    Br J Cancer 70:950-3. 1994

Collaborators

Detail Information

Publications70

  1. ncbi Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Int Angiol 22:250-62. 2003
    ....
  2. ncbi The relationship between lower urinary tract symptoms and health status: the UREPIK study
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    BJU Int 92:575-80. 2003
    ..To assess the hypothesis that as lower urinary tract symptoms (LUTS) increase in severity, the impact as measured by the BPH impact index (BII) would also increase...
  3. ncbi The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    BJU Int 92:719-25. 2003
    ....
  4. ncbi The prevalence of male urinary incontinence in four centres: the UREPIK study
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    BJU Int 92:943-7. 2003
    ..To report the results of the prevalence and health status associated with male urinary incontinence (UI) in a population-based, multicentre study in four countries, and to assess the epidemiology of this condition...
  5. ncbi Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
    P Maisonneuve
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Lancet 354:93-9. 1999
    ..The aim of this study was to examine the risk of cancer in a large cohort of patients treated by dialysis but not transplantation...
  6. ncbi The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    BJU Int 92:409-14. 2003
    ..To evaluate the epidemiology of lower urinary tract symptoms (LUTS) among men and women, as there are significant unanswered questions about the prevalence and impact of LUTS in different populations...
  7. ncbi Larynx cancer in Slovakia and the role of anatomical subsites
    G Severi
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Oral Oncol 35:564-70. 1999
    ..This supports the hypothesis that supraglottis cancer is more strongly linked to a synergistic effect of smoking and alcohol than glottis cancer...
  8. ncbi Projections to the end of the century of mortality from major cancer sites in Italy
    E Negri
    Istituto di Ricerche Farmacologiche M. Negri, Milan, Italy
    Tumori 76:420-8. 1990
    ....
  9. ncbi Age at any birth and breast cancer risk
    C Robertson
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milano, Italy
    Stat Med 17:431-45. 1998
    ..Various restrictions on the parameters of the general model yield the specific models. The models are applicable in case control studies and are illustrated using data from a case control study of breast cancer in Italy...
  10. pmc A case-control study of diabetes mellitus and cancer risk
    C La Vecchia
    Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    Br J Cancer 70:950-3. 1994
    ....
  11. pmc Mortality from cutaneous melanoma: evidence for contrasting trends between populations
    G Severi
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Br J Cancer 82:1887-91. 2000
    ..The three trend patterns we observed are in agreement with time differences between populations with respect to the promotion of sun protection and the surveillance of pigmented skin lesions...
  12. ncbi Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients
    S Gandini
    Division of Epidemiology and Biostatics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Eur J Cancer 36:636-46. 2000
    ..This analysis confirms the association between intake of vegetables and, to a lesser extent, fruits and breast cancer risk from published sources. Increasing vegetable consumption might reduce the risk of breast cancer...
  13. ncbi Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about?
    P Boyle
    European Institute of Oncology, Milan, Italy
    Ann Oncol 14:1312-25. 2003
    ..A programme of activities and research, focussing on three major themes [prevention (particularly tobacco control), screening, and education and training], was developed together with the European Code Against Cancer...
  14. ncbi Descriptive epidemiology of Hodgkin's disease in Italy
    C La Vecchia
    Institute for Pharmacological Research, Milan, Italy
    Tumori 75:401-5. 1989
    ....
  15. ncbi Effect of parity and age at delivery on breast cancer risk in Slovenian women aged 25-54 years
    C Robertson
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Int J Cancer 73:1-9. 1997
    ..A post-menopausal woman has a reduced breast cancer risk compared with a pre-menopausal woman of the same age, adjusting for the same number of deliveries and ages at these deliveries...
  16. ncbi Contribution of three components to individual cancer risk predicting breast cancer risk in Italy
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Eur J Cancer Prev 13:183-91. 2004
    ..Thus, the Gail model can be improved for use in other populations by using estimates of incidence and risk which are more appropriate to the target population...
  17. ncbi Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors
    G Severi
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Br J Dermatol 149:1207-13. 2003
    ..The epidemiology of androgenetic alopecia (AGA) is not fully understood. Although a strong genetic basis has long been identified, little is known of its non-genetic causes...
  18. ncbi Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia
    P Boyle
    Department of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    BJU Int 93:751-6. 2004
    ....
  19. pmc Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group
    A Decensi
    FIRC Chemoprovention Unit, European Institute of Oncology, Milan, Italy
    Br J Cancer 78:572-8. 1998
    ..Whereas a trial of tamoxifen in women already on transdermal HRT is warranted, prescription of HRT during tamoxifen may attenuate its activity...
  20. ncbi Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study
    P Maisonneuve
    Division of Epidemiology, European Institute of Oncology, Milan, Italy
    Am J Kidney Dis 35:157-65. 2000
    ....
  21. ncbi Current situation of screening for cancer
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Ann Oncol 13:189-98. 2002
  22. ncbi Cancer control in women. Update 2003
    P Boyle
    Dept of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Int J Gynaecol Obstet 83:179-202. 2003
    ..Although more work is needed, it is becoming clear that there could be an important role of HPV testing to further enhance cervix cancer screening...
  23. ncbi Meta-analysis of randomized trials of terazosin in the treatment of benign prostatic hyperplasia
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Urology 58:717-22. 2001
    ..Most importantly, the effect of terazosin on symptoms and peak urinary flow rate was independent of the baseline prostate size for the range of prostate volumes reported...
  24. ncbi Breast cancer incidence rates in Slovenia 1971-1993
    C Robertson
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Int J Epidemiol 29:969-74. 2000
    ....
  25. pmc Statistical modelling of breast cancer incidence and mortality rates in Scotland
    C Robertson
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Br J Cancer 76:1248-52. 1997
    ..There have been no changes in the mortality rate trends with period in Scotland, although the changes in the incidence rate trends with period are consistent with an increase in registration coverage...
  26. ncbi Rationale for a study adding tamoxifen to HRT
    N Rotmensz
    European Institute of Oncology, Milan, Italy
    Eur J Cancer 38:S22-3. 2002
  27. ncbi Cancer mortality in Ireland, 1926-1995
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Ann Oncol 14:323-32. 2003
    ..The information presented here will contribute to providing a basis for the collaborative Cancer Research programme initiated recently...
  28. doi Exposure to acrylamide and human cancer--a review and meta-analysis of epidemiologic studies
    C Pelucchi
    Department of Epidemiology, Mario Negri Institute for Pharmacological Research, Milan, Italy
    Ann Oncol 22:1487-99. 2011
    ..Acrylamide has been associated to cancer risk in rodents, but data on humans are inconclusive. We thus carried out a critical review and meta-analysis of studies of exposure to acrylamide and cancer...
  29. ncbi Epidemiological aspects of lip cancer in Scotland
    G J Macfarlane
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Community Dent Oral Epidemiol 21:279-82. 1993
    ..This decline has been the result of cohort effects indicating that the risk of lip cancer is decreasing among successively younger people...
  30. ncbi 5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Eur Urol 45:620-6; discussion 626-7. 2004
    ..This analysis examines the relative effectiveness of current medical therapies for BPH in preventing AUR, AUR-related catheterisation and surgery in real-life clinical practice...
  31. ncbi Biologic activity of tamoxifen at low doses in healthy women
    A Decensi
    Chemoprevention Unit, European Institute of Oncology, Milan, Italy
    J Natl Cancer Inst 90:1461-7. 1998
    ..Since these adverse effects may be dose related, we investigated the effect of tamoxifen on several biomarkers when the drug was given at doses lower than those currently in use...
  32. pmc Epidemiological features of gastric and oesophageal cancers in Slovakia
    G J Macfarlane
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Br J Cancer 70:177-9. 1994
    ..This is in keeping with observations made in central and eastern Europe of an increase in the incidence of tobacco- and alcohol-related cancers...
  33. ncbi Some further consideration on the role of oral contraceptives in breast carcinogenesis
    C La Vecchia
    Mario Negri Institute for Pharmacological Research, Milan, Italy
    Tumori 76:220-4. 1990
    ..Thus we suggest that, besides chance and bias, the apparent discrepancies between various studies should be considered within the framework of the complex time- and age-effects of hormone-related risk factors on breast carcinogenesis...
  34. ncbi Tamoxifen for breast cancer among hysterectomised women
    U Veronesi
    Divisions of Senology, European Institute of Oncology, Milan, Italy
    Lancet 359:1122-4. 2002
    ..So far, no woman has died from breast cancer in this study. Decisions about introduction of tamoxifen to reduce risk of breast cancer remain important and open questions...
  35. ncbi Screening for prostate cancer: have you had your cholesterol measured?
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    BJU Int 92:191-9. 2003
    ..The authors from the University of Stellenbosch review the plentiful literature relating to testicular torsion and functional recovery. They also review the mechanism of injury and the effect on the contralateral testis...
  36. ncbi European Code Against Cancer and scientific justification: third version (2003)
    P Boyle
    Department of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Ann Oncol 14:973-1005. 2003
  37. pmc The case of the disappearing nitrosamines: a potentially global phenomenon
    N Gray
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Tob Control 13:13-6. 2004
    ..This variation is both unacceptable and unnecessary, as TSNAs can be readily removed during the manufacturing process. Removing a known carcinogen needs no justification, even though proof of benefit may not be forthcoming for decades...
  38. ncbi Screening
    P Boyle
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Eur Respir J Suppl 39:3s-15s. 2003
    ..As the aim at present is to strive to maximise the effectiveness of population-based programmes, this aspect should be foremost in all thought processes...
  39. ncbi Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study
    J V Parle
    Division of Primary Care, Public and Occupational Health, Birmingham, UK
    Lancet 358:861-5. 2001
    ..2). INTERPRETATION: A single measurement of low serum thyrotropin in individuals aged 60 years or older is associated with increased mortality from all causes, and in particular mortality due to circulatory and cardiovascular diseases...
  40. ncbi Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria
    G Bartsch
    Department of Urology, University of Innsbruck, Innsbruck, Austria
    Urology 58:417-24. 2001
    ..It is our opinion that most of this decline is likely to be due to aggressive downstaging and successful treatment and that any contribution from detecting and treating early cancers will only become apparent in the years to come...
  41. pmc Lactation and breast cancer risk: a case-control study in Connecticut
    T Zheng
    Department of Epidemiology and Public Health, Yale University School of Medicine, 60 College, New Haven, CT 06520, USA
    Br J Cancer 84:1472-6. 2001
    ..These results support an inverse association between breastfeeding and breast cancer risk...
  42. ncbi [Erectile dysfunction: prevalence and effect on the quality of life; Boxmeer study]
    E J Meuleman
    Universitair Medisch Centrum St Radboud, afd Urologie, Postbus 9101, 6500 HB Nijmegen
    Ned Tijdschr Geneeskd 145:576-81. 2001
    ..To assess the prevalence of erectile dysfunction (ED), and its influence on both the quality of life, and health care seeking behaviour...
  43. ncbi Trends in cancer mortality in the European Union and accession countries, 1980-2000
    F Levi
    Cancer Epidemiology Unit, Institut Universitaire de Medecine Sociale et Preventive, Lausanne, Switzerland
    Ann Oncol 15:1425-31. 2004
    ..Consequently, the application of available knowledge on cancer prevention, diagnosis and treatment may substantially reduce the disadvantage now registered in the cancer mortality of central and eastern European accession countries...
  44. ncbi Cancer incidence and mortality in Europe, 2004
    P Boyle
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Ann Oncol 16:481-8. 2005
    ..Those data that are available generally refer to the mid-1990s and are of limited use for cancer control planning. We present estimates of the cancer burden in Europe in 2004, including data for the (25 Member States) European Union...
  45. ncbi Use of hair colouring products and breast cancer risk: a case-control study in Connecticut
    T Zheng
    Yale School of Public Health, 60 College Street, New Haven, CT 06520, USA
    Eur J Cancer 38:1647-52. 2002
    ..These data suggest that the use of hair colouring products does not have a major impact on the risk of breast cancer...
  46. ncbi Estimates of the cancer incidence and mortality in Europe in 2006
    J Ferlay
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Ann Oncol 18:581-92. 2007
    ..Monitoring the evolution of the cancer burden in Europe is of great value. Estimates of the cancer burden in Europe have been published for 2004 and estimates are now being presented for cancer incidence and mortality in Europe for 2006...
  47. pmc Impact on mortality following first acute myocardial infarction of distance between home and hospital: cohort study
    L Wei
    Medicines Monitoring Unit, Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK
    Heart 94:1141-6. 2008
    ..To investigate the effect of distance between home and acute hospital on mortality outcome of patients experiencing an incident myocardial infarction (MI)...
  48. doi Need for global action for cancer control
    P Boyle
    Ann Oncol 19:1519-21. 2008
  49. ncbi [Prevalence of lower urinary tract disorders and incontinence in Auxerre. French segment of the UrEpik study]
    R O Fourcade
    Centre hospitalier d Auxerre, Service d Urologie, F 89000 Auxerre, France
    Presse Med 31:202-10. 2002
    ..To estimate the prevalence of low urinary tract symptoms (LUTS) and urinary incontinence among men and women aged 40 to 79 years...
  50. ncbi Overview of the main outcomes in breast-cancer prevention trials
    J Cuzick
    Cancer Research UK, London, UK
    Lancet 361:296-300. 2003
    ..Early findings on the use of tamoxifen or raloxifene as prophylaxis against breast cancer have been mixed; we update available data and overview the combined results...
  51. ncbi Global summit on mammographic screening
    P Boyle
    Ann Oncol 14:1159-60. 2003
  52. ncbi Mortality from major cancer sites in the European Union, 1955-1998
    F Levi
    Unité d Epidémiologie du Cancer and Registres Vaudois et Neuchâtelois des Tumeurs, Institut Universitaire de Medecine Sociale et Preventive, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
    Ann Oncol 14:490-5. 2003
    ..Lung cancer rates in European women have also tended to stabilise below the age of 75 years. Thus, effective interventions on tobacco control could, in principle, avoid a major lung cancer epidemic in European women...
  53. ncbi Cancer mortality trends in the EU and acceding countries up to 2015
    M J Quinn
    National Cancer Intelligence Centre, Office for National Statistics, London, UK
    Ann Oncol 14:1148-52. 2003
    ....
  54. pmc Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease
    N Hamajima
    Cancer Research UK Epidemiology Unit, Gibson Building, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK
    Br J Cancer 87:1234-45. 2002
    ....
  55. ncbi The importance of benign urological disease in communities
    P Boyle
    Surgical Professorial Unit, Mater Misericordiae Hospital, Dublin, Republic of Ireland
    BJU Int 92:342-3. 2003
  56. ncbi Improvements in benign prostatic hyperplasia-specific quality of life with dutasteride, the novel dual 5alpha-reductase inhibitor
    M P O'Leary
    Department of Surgery, Harvard Medical School, Division of Urology, Brigham and Women s Hospital, Boston, USA
    BJU Int 92:262-6. 2003
    ....
  57. ncbi Neural response imaging (NRI) cochlear mapping: prospects for clinical application
    L Arnold
    Advanced Bionics SARL, 76 rue de Battenheim, 68170 Rixheim, France
    Cochlear Implants Int 8:173-88. 2007
    ..Cochlear mapping provided repeatable data that gave interesting insights into the implanted cochlea. Further work is required to determine whether this approach could contribute to programme optimisation...
  58. doi Favorable trends in cancer mortality in the European Union but no room for complacency
    P Boyle
    Ann Oncol 19:605-6. 2008
  59. doi Factors influencing attitudes to legislation banning the manufacture and sale of tobacco products
    J G Park
    Tob Control 17:142-3. 2008
  60. doi Diet, nutrition and cancer: public, media and scientific confusion
    P Boyle
    Ann Oncol 19:1665-7. 2008
  61. pmc Trends in mortality from Hodgkin's disease in western and eastern Europe
    F Levi
    Cancer Epidemiology Unit and Cancer Registries of Vaud and Neuchâtel, Institut Universitaire de Medecine Sociale et Preventive, CHUV Falaises 1, 1011 Lausanne, Switzerland
    Br J Cancer 87:291-3. 2002
    ..Eastern European countries, however, showed only an approximately 40% decline between the late 1960's and the early 1990's, and no further fall thereafter...
  62. pmc Glutathione S-transferase M1 and T1 genetic polymorphisms, alcohol consumption and breast cancer risk
    T Zheng
    Department of Epidemiology and Public Health, Yale University School of Medicine, 60 College, New Haven, CT, USA
    Br J Cancer 88:58-62. 2003
    ..In conclusion, alcohol consumption may increase breast cancer risk among those who carry susceptible GST genotypes...
  63. pmc Tobacco smoking and the British doctors' cohort
    P Boyle
    Br J Cancer 92:419-20. 2005
  64. ncbi Workgroup I: criteria for screening. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002)
    P Boyle
    International Agency for Research on Cancer, Lyon, France
    Ann Oncol 16:25-30. 2005
  65. ncbi Sexual factors and prostate cancer
    G G Giles
    Cancer Epidemiology Centre, and Centre for Behavioural Research in Cancer, The Cancer Council Victoria, Melbourne, Australia
    BJU Int 92:211-6. 2003
    ..To assess whether prostate cancer might be related to hormone levels and, by inference, to differences in sexual activity...
  66. ncbi Dietary glycemic load and colorectal cancer risk
    S Franceschi
    Servizio di Epidemiologia, Centro di Riferimento Oncologico, Istituto Nazionale Tumori, Aviano, Italy
    Ann Oncol 12:173-8. 2001
    ..CONCLUSIONS: The positive associations of glycemic index and load with colorectal cancer suggest a detrimental role of refined carbohydrates in the etiology of the disease...
  67. ncbi A case-control study of occupation and breast-cancer risk in Connecticut
    T Zheng
    Yale University School of Medicine, Yale Cancer Center, New Haven, CT, USA
    J Cancer Epidemiol Prev 7:3-11. 2002
    ..The results, however, are inconsistent. We analyse data from a case-control study of breast cancer in Connecticut conducted in 1994-97 to further examine the potential relationship between occupation and breast-cancer risk...
  68. ncbi Faecal occult blood testing (FOBT) as screening for colorectal cancer: the current controversy
    P Boyle
    Ann Oncol 13:16-8. 2002
  69. ncbi Regulation of cigarette emissions
    N Gray
    Ann Oncol 13:19-21. 2002
  70. ncbi Preventing the lung cancer epidemic
    P Boyle
    Ann Oncol 16:1565-6. 2005